We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, July 10th:
Unum Therapeutics Inc. : This biopharmaceutical company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 45.1% over the last 60 days.
Unum Therapeutics’ shares gained more than 100% over the last one month against the S&P 500 decline of 1.7%. The company possesses a Momentum Score of A.
Nautilus, Inc. : This fitness solution company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.
Pacira BioSciences, Inc. (PCRX - Free Report) : This non-opioid pain management and regenerative health solutions provider has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.8% over the last 60 days.
BrightSphere Investment Group Inc. (BSIG - Free Report) : This asset management holding company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 13.2% over the last 60 days.
BrightSphere Investment Group Inc. Price and Consensus
The COVID-19 outbreak has shifted consumer behavior dramatically, and a handful of high-tech companies have stepped up to keep America running. Right now, investors in these companies have a shot at serious profits. For example, Zoom jumped 108.5% in less than 4 months while most other stocks were sinking.
Our research shows that 5 cutting-edge stocks could skyrocket from the exponential increase in demand for “stay at home” technologies. This could be one of the biggest buying opportunities of this decade, especially for those who get in early.
Image: Bigstock
Top Ranked Momentum Stocks to Buy for July 10th
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, July 10th:
Unum Therapeutics Inc. : This biopharmaceutical company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 45.1% over the last 60 days.
Unum Therapeutics Inc. Price and Consensus
Unum Therapeutics Inc. price-consensus-chart | Unum Therapeutics Inc. Quote
Unum Therapeutics’ shares gained more than 100% over the last one month against the S&P 500 decline of 1.7%. The company possesses a Momentum Score of A.
Unum Therapeutics Inc. Price
Unum Therapeutics Inc. price | Unum Therapeutics Inc. Quote
Nautilus, Inc. : This fitness solution company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.
Nautilus Group, Inc. The Price and Consensus
Nautilus Group, Inc. The price-consensus-chart | Nautilus Group, Inc. The Quote
Nautilus’ shares gained 60.2% over the last one month. The company possesses a Momentum Score of A.
Nautilus Group, Inc. The Price
Nautilus Group, Inc. The price | Nautilus Group, Inc. The Quote
Pacira BioSciences, Inc. (PCRX - Free Report) : This non-opioid pain management and regenerative health solutions provider has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.8% over the last 60 days.
Pacira BioSciences, Inc. Price and Consensus
Pacira BioSciences, Inc. price-consensus-chart | Pacira BioSciences, Inc. Quote
Pacira BioSciences’ shares gained 18.7% over the last one month. The company possesses a Momentum Score of A.
Pacira BioSciences, Inc. Price
Pacira BioSciences, Inc. price | Pacira BioSciences, Inc. Quote
BrightSphere Investment Group Inc. (BSIG - Free Report) : This asset management holding company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 13.2% over the last 60 days.
BrightSphere Investment Group Inc. Price and Consensus
BrightSphere Investment Group Inc. price-consensus-chart | BrightSphere Investment Group Inc. Quote
BrightSphere Investment's shares gained 30% over the last one month. The company possesses a Momentum Score of A.
BrightSphere Investment Group Inc. Price
BrightSphere Investment Group Inc. price | BrightSphere Investment Group Inc. Quote
See the full list of top ranked stocks here.
Learn more about the Momentum score and how it is calculated here.
These Stocks Are Poised to Soar Past the Pandemic
The COVID-19 outbreak has shifted consumer behavior dramatically, and a handful of high-tech companies have stepped up to keep America running. Right now, investors in these companies have a shot at serious profits. For example, Zoom jumped 108.5% in less than 4 months while most other stocks were sinking.
Our research shows that 5 cutting-edge stocks could skyrocket from the exponential increase in demand for “stay at home” technologies. This could be one of the biggest buying opportunities of this decade, especially for those who get in early.
See the 5 high-tech stocks now>>